Skip to main content
Clinical Trials/NCT01262157
NCT01262157UnknownPhase 3

A Clinical Randomized Double Blind Placebo Controlled Study on the Effect of Low Intensity Shock Wave Therapy for Erectile Dysfunction in a Group of Patients Not Responding to Oral Therapy

Rambam Health Care Campus1 site in 1 country60 target enrollmentStarted: April 1, 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 3
Enrollment
60
Locations
1
Primary Endpoint
IIEF-ED Domain

Study Overview

Brief Summary

Low intensity shock waves (LISW) have been proven in animal studies to induce local growth of new blood vessels. The investigators hypothesized that LISW therapy could improve the symptoms of patients with erectile dysfunction resulting from a problem of blood supply that do not respond to oral therapy (PDE-5 inhibitors).

Detailed Description

In this study Low intensity shockwaves (1/10 the ones used in Lithotripsy) are delivered directly to the penile tissue using a specially designed shockwave device and probe. Shock wave therapy is applied twice a week for three weeks , then a 3- week interval with no therapy followed by another 3 week period of twice a week shock wave therapy. Before and after sexual function questionnaires and objective measures of erectile function will be performed.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to 85 Years (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •ED of more than 6 months
  • •Rigidity score < 3 during PDE5i therapy
  • •SHIM <21 during PDE5i therapy
  • •Non- hormonal, neurological or psychological pathology Stable heterosexual relationship for more than 3 months

Exclusion Criteria

  • •Prior prostatectomy surgery
  • •Any unstable medical, psychiatric, spinal cord injury and penile anatomical abnormalities
  • •Clinically significant chronic hematological disease
  • •Anti-androgens, oral or injectable androgens
  • •Radiotherapy in pelvic region

Arms & Interventions

placebo

Sham Comparator

We use the same probe that induces the same sensation on the penis and the same noise yet no energy

Intervention: Extracorporeal Shockwave Therapy Generator (Vascuspec) (Device)

Shock wave therapy

Active Comparator

12 treatment sessions twice a week during 9 weeks with an interim of 3 weeks no treatment

Intervention: Low intensity shock wave therapy (Device)

Outcomes

Primary Outcomes

IIEF-ED Domain

Time Frame: 17 weeks

A change of 5 points or more will indicate success

Secondary Outcomes

  • rigidity score(17 weeks)

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials